AstraZeneca Pharmaceuticals LP
2871 articles about AstraZeneca Pharmaceuticals LP
-
AstraZeneca PLC Release: New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
7/31/2013
-
Dotmatics Cloud Hosted Platform Enables AstraZeneca PLC Neuroscience Drug Discovery Collaborations
7/25/2013
-
AstraZeneca PLC and Bristol-Myers Squibb Company Resubmit Dapagliflozin New Drug Application for the Treatment of Type 2 Diabetes in the U.S.
7/25/2013
-
AstraZeneca PLC, Pfizer Inc., Novartis Among Suitors for Onyx Pharmaceuticals, Inc.
7/23/2013
-
2 More AstraZeneca PLC Employees Questioned in CN
7/23/2013
-
Chinese Police Pays Visit to AstraZeneca PLC Office
7/22/2013
-
Omthera Pharmaceuticals, Inc. Stockholders Approve Acquisition by AstraZeneca PLC
7/16/2013
-
AstraZeneca PLC Takes a More Personal Approach to Connecting with NEXIUM® (Esomeprazole Magnesium) Patients
7/16/2013
-
AstraZeneca PLC CFO Jumps Ship to BG Group
7/15/2013
-
AstraZeneca PLC Signs Cambridge-Based Cancer Research Collaboration
7/10/2013
-
Blackfield Announces Fourth Major Pharmaceutical Company Collaboration
7/8/2013
-
AstraZeneca PLC Backs Another Cambridge Biotech
7/3/2013
-
Dissident VIVUS, Inc. Holder Eyes Ex-AstraZeneca PLC Exec for CEO
7/2/2013
-
AstraZeneca PLC Partners Up With Academia in $100 Million Deal
7/1/2013
-
An Inside Look Into AstraZeneca PLC, Roche's Shared Data Deal
6/27/2013
-
Rivals Roche and AstraZeneca PLC to Share Drug Research Data
6/26/2013
-
AstraZeneca PLC to Hire 80 in Waltham, MA
6/26/2013
-
AstraZeneca PLC Shifts Some Service Jobs Overseas
6/25/2013
-
A Bristol-Myers Squibb Company and AstraZeneca PLC Diabetes Trial is a "Dud"
6/24/2013
-
AstraZeneca PLC Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016
6/19/2013